Mefenorex

Mefenorex

Clinical data
Trade names	Rondimen, Pondinil, Anexate
ATC code	A08AA09 ( WHO )
Legal status
Legal status	BR: Class B2 (Anorectic drugs) [1] CA: Schedule I DE: Anlage II (Authorized trade only, not prescriptible)
Identifiers
IUPAC name 3-chloro-N-(1-methyl-2-phenylethyl)propan-1-amine
CAS Number	17243-57-1  Y
PubChem CID	21777
ChemSpider	20467  Y
UNII	K98M4N387W
KEGG	D07891  Y
CompTox Dashboard (EPA)	DTXSID6057665
ECHA InfoCard	100.037.511
Chemical and physical data
Formula	C12H18ClN
Molar mass	211.73 g·mol−1
3D model (JSmol)	Interactive image
SMILES ClCCCNC(Cc1ccccc1)C
InChI InChI=1S/C12H18ClN/c1-11(14-9-5-8-13)10-12-6-3-2-4-7-12/h2-4,6-7,11,14H,5,8-10H2,1H3 Y Key:XXVROGAVTTXONC-UHFFFAOYSA-N Y
(verify)

Mefenorex (marketed as Rondimen, Pondinil, Anexate) is an amphetamine derivative with a relatively mild psychostimulant profile. Developed in the 1960s, it was used throughout the 1970s as an appetite suppressant for treating obesity. ^{[2] [3]} Mefenorex is a prodrug of amphetamine; upon ingestion, the compound will begin to metabolize into, as well as promote the production of, the active metabolites levoamphetamine and dextroamphetamine. ^[4] Multiple sources have noted the substance as exerting "mild stimulant effects....[and having] relatively little abuse potential." ^[5]

References

1. Anvisa (31 March 2023). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 4 April 2023). Archived from the original on 3 August 2023. Retrieved 16 August 2023.
2. Vincendeau MJ (1970). "[A new regulator of appetite: mefenorex]". Bordeaux Medical (in French). 3 (7): 1951–3. PMID   5455004.
3. Beyer G, Huth K, Müller GM, Niemöller H, Raisp I, Vorberg G (February 1980). "[The treatment of obesity with the appetite curbing agent Mefenorex]". Die Medizinische Welt (in German). 31 (8): 306–9. PMID   7374423.
4. Rendić S, Slavica M, Medić-Sarić M (1994). "Urinary excretion and metabolism of orally administered mefenorex". European Journal of Drug Metabolism and Pharmacokinetics. 19 (2): 107–17. doi:10.1007/BF03188831. PMID   8001591. S2CID   7170057.
5. Engel J, Kristen G, Schaefer A, von Schlichtegroll A (June 1986). "Mefenorex (Rondimen)". Drug and Alcohol Dependence. 17 (2–3): 229–34. doi:10.1016/0376-8716(86)90010-4. PMID   3743406.